Allergy Therapeutics Share Discussion Threads

[jimmyloser] 04/12/2024 15:19

I should bloody think so mm's, the dynamite worked lol

[totally banjo] 04/12/2024 11:45

This mornings news is very positive but the PROTECT trial is not completed as yet!

The PROTECT trial is due for completion H2 2025 so not long to wait and if successful
then that is major news!

[jimmyloser] 04/12/2024 10:41

FarmerG,
You may recall that last week I lightheartedly suggested that to get the share price moving it needed a dose of Senokot.
Judging by the lack of any response to the stream of positive newsflow, I now upgrade my suggestion to DYNAMITE!

lol

impo

[farmergeorge] 04/12/2024 10:18

Excellent news, let's now see some significant upwards price movement.

[totally banjo] 04/12/2024 09:59

Great news this morning!

sleveen, I've just C&P a previous post, it was easier :-)

"Anaphylaxis is "a severe, potentially life-threatening allergic reaction" with one major cause being peanuts where sufferers are required to carry an EpiPen or perhaps use the new nasal spray.

Therefore if AGY's peanut allergy vaccine is successful people with a previous allergy would potentially not get to the anaphylaxis stage and hence not need or have to carry with them an EpiPen or new nasal spray at all times!"

[sleveen] 04/12/2024 07:58

Does it prevent anaphylaxis on exposure to the antigen that's the endpoint needed?

Surrogate markers like weal size reduction are merely a hopeful pointer to possible therapeutic management.

[jimmyloser] 04/12/2024 07:32

This is excellent news this morning and I thank and congratulate everybody involved in bringing this much needed product to this stage. It can't be in market a day too soon.Having been in AGY for a decade or so, it is nice to see them consistently delivering on so many fronts as they have indicated they would.It takes some comprehending that here we have a small British business that has not one but two potentially global blockbuster products coming down the pipe at some speed.To think that one can buy a share in that business for a few pennies beggars beliefImpo

[coinbase] 04/12/2024 07:04

POSITIVE INTERIM DATA FROM PROTECT TRIAL - hXXps://www.londonstockexchange.com/news-article/AGY/positive-interim-data-from-protect-trial/16794189

[coinbase] 28/11/2024 13:28

Two cracking links. The numbers need to be seen to be believed.

hXXps://www.barchart.com/story/news/29771736/peanut-allergy-market-report-2034-epidemiology-data-pipeline-therapies-latest-fda-ema-pdma-approvals-by-delveinsight-vedanta-biosciences-inc-allergy-therapeutics-cour-pharmaceutical-develop

hXXps://www.grandviewresearch.com/horizon/outlook/allergy-diagnostics-and-therapeutics-market/germany

[totally banjo] 27/11/2024 12:32

Allergy Therapeutics begins paediatric trial for grass allergy treatment
07:39 27 Nov 2024 GMT

Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) has commenced a phase III trial to test the long-term safety and effectiveness of its Grass MATA MPL allergy treatment in children.

This marks the first industry trial of its kind for paediatric patients with grass pollen-induced allergic rhinitis.

Grass MATA MPL uses an innovative formula that includes microcrystalline tyrosine and monophosphoryl-lipid A, requiring just six doses before the grass allergy season.

The treatment aims to reduce allergy symptoms and the need for medication.

The paediatric trial follows the successful phase III G306 trial in adults, where Grass MATA MPL showed significant reductions in allergy symptoms compared to a placebo.

Results from that study supported a regulatory application to Germany's Paul Ehrlich Institut.

This latest trial aims to determine whether the treatment is safe and effective for children over the long term. If successful, it could expand options for managing grass pollen allergies in younger patients.

"The start of the Phase III G308 trial investigating the efficacy and safety of our Grass MATA MPL in a paediatric population marks an exciting step in bringing this innovative treatment to further patients affected by grass allergies," said Manuel Llobet, CEO of Allergy Therapeutics.

"Building on our successful adult trials, this study will help us understand how our short-course immunotherapy can benefit children affected by grass allergies, potentially transforming their treatment journey."

[jimmyloser] 26/11/2024 15:35

For a business that is finally delivering on all of its promises, this looks as if it needs a strong dose of Senokot to get it moving. Either that or some exciting data on the PROTECT project.

Coming soon, hopefully.

impo

[jpuff] 25/11/2024 14:16

Yes and hopefully upwards! I guess with all that's going on in the wider world at the moment the market is perhaps not so focused on allergies in folk.

[farmergeorge] 25/11/2024 12:41

Great news,so let's see some price movement ;-).

[totally banjo] 25/11/2024 12:10

In the media:

Allergy Therapeutics applies for full marketing approval for grass allergy jab
Published: 07:29 25 Nov 2024 GMT

"Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) marked a 'significant milestone' after it applied for regulatory approval of its new grass allergy immunotherapy.

The submission, made to Germany’s Paul Ehrlich Institut (PEI), includes evidence from a phase III clinical trial showing significant symptom reduction during peak pollen season.

The therapy, called Grass MATA MPL, is an injectable treatment targeting allergic rhinoconjunctivitis caused by grass pollen."


""The submission of the MAA to the PEI in Germany marks a significant milestone in our regulatory pathway and brings us closer to potentially offering an important new treatment option for patients affected by seasonal grass allergy," said Manuel Llobet, CEO of Allergy Therapeutics.

"We look forward to continuing to work closely with the PEI during the review process of the MAA and I would like to thank the team at Allergy Therapeutics for their dedication in advancing this innovative product toward market.""

[totally banjo] 25/11/2024 09:56

lol yes, all going to plan!

[jimmyloser] 25/11/2024 07:03

Sing Hallelujah, I'm beginning to see the light!

[farmergeorge] 22/11/2024 21:23

Let's hope AGY are heading in the right direction out of the tunnel. All have a good weekend.

[jimmyloser] 22/11/2024 16:19

FarmerG,An excellent answer.It brought a smile on this dreich afternoon.

[totally banjo] 22/11/2024 16:18

Always try to help :-)

[farmergeorge] 22/11/2024 16:09

totally banjo, thanks for that,made all the difference.

[totally banjo] 22/11/2024 15:58

farmerg, that's because you're looking the wrong way! Turn around and face forwards to the future and you will see the light :-)

[farmergeorge] 21/11/2024 22:06

Jimmyloser, I'm with you on all of that. However, I'm in the tunnel but cant quite see the light,yet.

[jimmyloser] 21/11/2024 21:46

FarmerGI am currently really happy. This is by necessity a slow burn. I have been in for years.Finally, I can see light at the end of the tunnel.I like the fact that money is available.Management are being incentivised.We have a solid board of directors.We have a lead over world players.Our products have huge markets and are needed.Tomorrow is another day!Keep the faith Impo